Treatment of the CLL samples with ONC‐212 while in co‐culture with stromal cells resulted in a significant attenuation of the stroma‐induced phosphorylation of both AKT and ERK1/2‐MAPK. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.